Andrew Pink

机构：King's College London, Guy's and St Thomas' NHS Foundation Trust · ORCID：0000-0001-5151-5539

发表论文 183 篇 · 总被引 4769 次 · h-index 32

代表论文

• Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents (2025 · New England Journal of Medicine · 被引 26)
• Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials (2025 · The Lancet · 被引 15)
• Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 6)
• Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 6)
• Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials (2025 · British Journal of Dermatology · 被引 6)
• Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2) (2025 · Dermatology and Therapy · 被引 4)